Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125072) titled 'Evolocumab for ImproVing FunctiOnal Outcomes in ThromboLyzed Patients with Acute Ischemic Stroke without Large VEssel Occlusion: A Prospective, Multicenter, Randomized Controlled Trial (EVOLVE-Stroke I)' on May 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Condition:
Ischemic Stroke
Intervention:
Control group:Guideline-recommended standard of care, including atorvastatin, rosuvastatin, etc.
Recruitment Status: Recruiting
Phase: 2
Date of First Enrollment: 2026-05-21
Target Sample Size...